Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chehab, Nabil H.
Malikzay, Asra
Stavridi, Elena S.
and
Halazonetis, Thanos D.
1999.
Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.
Proceedings of the National Academy of Sciences,
Vol. 96,
Issue. 24,
p.
13777.
Chehab, Nabil H.
Malikzay, Asra
Appel, Michael
and
Halazonetis, Thanos D.
2000.
Chk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53.
Genes & Development,
Vol. 14,
Issue. 3,
p.
278.
Nohaile, M. J.
Hendsch, Z. S.
Tidor, B.
and
Sauer, R. T.
2001.
Altering dimerization specificity by changes in surface electrostatics.
Proceedings of the National Academy of Sciences,
Vol. 98,
Issue. 6,
p.
3109.
Chène, Patrick
2001.
The role of tetramerization in p53 function.
Oncogene,
Vol. 20,
Issue. 21,
p.
2611.
Barlev, Nickolai A.
Liu, Lin
Chehab, Nabil H.
Mansfield, Kyle
Harris, Kimberly G.
Halazonetis, Thanos D.
and
Berger, Shelley L.
2001.
Acetylation of p53 Activates Transcription through Recruitment of Coactivators/Histone Acetyltransferases.
Molecular Cell,
Vol. 8,
Issue. 6,
p.
1243.
Bullock, Alex N.
and
Fersht, Alan R.
2001.
Rescuing the function of mutant p53.
Nature Reviews Cancer,
Vol. 1,
Issue. 1,
p.
68.
Deng, Honying
Kowalczyk, Dariusz
O, InSug
Blaszczyk-Thurin, Magdalena
Quan Xiang, Zhi
Giles-Davis, Wynetta
and
Ertl, Hildegund C.J
2002.
A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line.
Cellular Immunology,
Vol. 215,
Issue. 1,
p.
20.
MENG, RAYMOND D.
and
EL-DEIRY, WAFIK S.
2002.
Gene Therapy of Cancer.
p.
299.
Stavridi, Elena S.
Huyen, Yentram
Sheston, Emily A.
and
Halazonetis, Thanos D.
2005.
The p53 Tumor Suppressor Pathway and Cancer.
Vol. 2,
Issue. ,
p.
25.
Poon, Gregory M.K.
Brokx, Richard D.
Sung, Michael
and
Gariépy, Jean
2007.
Tandem Dimerization of the Human p53 Tetramerization Domain Stabilizes a Primary Dimer Intermediate and Dramatically Enhances its Oligomeric Stability.
Journal of Molecular Biology,
Vol. 365,
Issue. 4,
p.
1217.
Webber, Tawnya M.
Allen, Andrew C.
Ma, Wai Kit
Molloy, Rhett G.
Kettelkamp, Charisse N.
Dow, Caitlin A.
and
Gage, Matthew J.
2009.
Conformational detection of p53’s oligomeric state by FlAsH Fluorescence.
Biochemical and Biophysical Research Communications,
Vol. 384,
Issue. 1,
p.
66.
Lui, Ki
Sheikh, M. Saeed
and
Huang, Ying
2015.
Regulation of p53 oligomerization by Ras superfamily protein RBEL1A.
Genes & Cancer,
Vol. 6,
Issue. 7-8,
p.
307.
Chen, Changjin
Zhao, Ziyi
Tang, Shiyun
and
Zhang, Cuiwei
2018.
Rab‑like protein 1 A is upregulated by cisplatin treatment and partially inhibits chemoresistance by regulating p53 activity.
Oncology Letters,